natgillin/translations-raw huggingface dataset:
Disse tilfælde er ekskluderet i analysen for HPV-type-bestemmelse (se under tabel).
These cases are excluded in the HPV type assignment analysis (see under Table).
Disse tilfælde er sædvanligvis forbigående og kortvarige.
These occurrences are generally self-limiting and of short duration.
Disse tilfælde er sædvanligvis forbigående og kortvarige.
Theses occurrences are generally self-limiting and of short duration.
Disse tilfælde forekom ved ikke-godkendte indikationer, og de fleste patienter var hiv- positive.
These cases occurred in non-approved indications and the majority of patients were HIV positive.
Disse tilfælde forekom ved ikke-godkendte indikationer, og de fleste patienter var hiv-positive.
These cases occurred in non-approved indications and the majority of patients were HIV positive.
Disse tilfælde forsvinder normalt inden for få uger ved fortsat insulinbehandling.
These usually disappear after a few weeks of taking your insulin.
Disse tilfælde taget i betragtning har PRAC bemærket, at der er visse formuleringer i produktresuméet og/eller indlægssedlen, der kan misforstås, eftersom de nævner administration med sprøjte, men ikke entydigt klargør, at Carbaglu kun er til oral administration.
When considering these cases, the PRAC noted that there is the potential for certain wording in the summary of product characteristics (SmPC) and/or in the patient leaflet to be misinterpreted as it mentions administration by syringe but does not unequivocally clarify that Carbaglu is for oral administration only.
Disse tilfælde var generelt af en mild karakter.
These events were generally mild in nature.
Disse tilstande og andre symptomer og tegn, som generelt er forbundet med GH-behandling, skal monitoreres under behandling med INCRELEX.
These conditions and other symptoms and signs known to be associated with GH treatment in general should be monitored during INCRELEX treatment.
Disse ting blandes til at danne den injektionsvæske, du skal tage.
These are mixed together to make up the injection you take (solution for injection).
Disse to komponenter nedsætter forhøjet intraokulært tryk (IOT) gennem komplementære virkningsmekanismer, og den samlede virkning medfører en øget trykreduktion i forhold til hvert af stofferne givet som monoterapi.
These two components decrease elevated intraocular pressure (IOP) by complementary mechanisms of action and the combined effect results in additional IOP reduction compared to either compound administered alone.
Disse transaminaseforhøjelser var generelt asymptomatiske, ikke- progredierende og ikke associeret med kolestase eller gulsot.
These elevations in transaminases were generally asymptomatic, non-progressive in nature and not associated with cholestasis or jaundice.
Disse transportører har dog minimal indflydelse på biotilgængeligheden og elimineringen af oralt dabrafenib, og risikoen for klinisk relevante interaktioner med hæmmere af P-gp og BCRP er lav.
However, these transporters have minimal impact on dabrafenib oral bioavailability and elimination and the risk for clinically relevant drug-drug interactions with inhibitors of Pgp or BCRP is low.
Disse trombocytændringer er ikke til stede hos rotter eller hos mennesker baseret på kliniske korttids- eller begrænsede langtidsdata.
These platelet changes were not present in rats or in humans based on short-term and limited long- term clinical data.
Disse tumorer menes at være spontane nyrecellekarcinomer, som er kendt for at forekomme hos gamle ikkehumane primater, og som sandsynligvis ikke er relevante for mennesker.
These tumours are considered as spontaneous renal cell carcinomas that are known to occur in aged nonhuman primates and are unlikely to be relevant to humans.
Disse typer lægemidler vil nedsætte din årvågenhed og gøre det svært for dig at føre motorkøretøj eller betjene maskiner.
These types of medicines will reduce you alertness levels making it difficult for you to drive and use machines.
Disse undersøgelser antyder, at potentiel carcinogenicitet af ribavirin hos mennesker er usandsynlig.
These studies suggest that a carcinogenic potential of ribavirin in humans is unlikely.
Disse undersøgelser har til formål at undersøge lægemidlets sikkerhed og virkning og at undersøge, hvordan det anvendes i det virkelige liv.
These studies will look at the medicine’s safety and effectiveness, and how it is used in real life.
Disse undersøgelser og resultaterne heraf bør registreres på dit barns patientkort.
The conduct and results of these tests should be recorded on your child's Patient Alert Card.
Disse undersøgelser var udformet således, at vaccinens effekt kunne påvises i tilfælde af PMWS- udbrud: De udvalgte besætninger havde tidligere været ramt af PMWS, og man kunne bekræfte forekomsten af sygdommen inden starten på de pågældende undersøgelser, med udgangspunkt i internationalt godkendte standarder.
These studies were well-designed to demonstrate the efficacy of the vaccine in the face of PMWS outbreaks: farms that were selected had a history of PMWS and the disease was confirmed to occur before starting of the respective studies, using internationally accepted standards.
Disse undersøgelser vedrørte virkningen af at tilføje Avastin til en kombinationsbehandling med carboplatin og gemcitabin eller til paclitaxel, topotecan eller pegyleret liposomalt doxorubicin.
These studies looked at the effect of adding Avastin to a combination treatment with carboplatin and gemcitabine or to paclitaxel, topotecan, or pegylated liposomal doxorubicin.
Disse undersøgelsesdata er ikke tilstrækkelige til at påvise virkning, og pædiatrisk anvendelsen af Kineret frarådes derfor i tilfælde af juvenil reumatoid artrit.
These study data are insufficient to demonstrate efficacy and, therefore, Kineret is not recommended for pediatric use in Juvenile Rheumatoid Arthritis.
Disse var alle grad 1 eller 2 med undtagelse af ét tilfælde af grad 3 forhøjet alanin-aminotransferase.
These were all CTCAE grade 1 and 2 with the exception of one CTCAE grade 3 raised alanine aminotransferase event.
Disse var observeret i kliniske forsøg, der indikerer at frekvensen af disse hændelser er 0,01 %, hvilket ifølge CIOMS III definition, svarer til en frekvens kategori, der anses for at være ‘sjælden’ (≥1/10.000, <1/1.000).
0.01 % which in the corresponding frequency category based on the CIOMS III convention is considered as ‘rare’ (>1/10,000, <1/1,000).
Disse var primært asymptomatiske hiv-inficerede patienter – Centre for Disease Control and Prevention (CDC) stadie A. De blev randomiseret til at modtage enten abacavir 600 mg én gang daglig eller 300 mg 2 gange daglig, i kombination med efavirenz og lamivudin givet én gang daglig.
These were primarily asymptomatic HIV infected patients - Centre for Disease Control and Prevention (CDC) stage A. They were randomised to receive either abacavir 600 mg once daily or 300 mg twice daily, in combination with efavirenz and lamivudine given once daily.
Disse var sammenlignelige i de 2 grupper, og forskellen mellem grupperne oversteg ikke ≥2 %.
These were comparable between groups, and the difference between groups did not exceed ≥2% incidence for the ZALTRAP/FOLFIRI regimen.
Disse vil normalt aftage efter nogle minutter uden at kræve behandling.
This will normally resolve within minutes without requiring treatment.
Disse virker imidlertid ikke hæmmende på væksten.
However these have no growth-inhibiting effects.
Disse virkninger af capsaicin, der optræder på et senere stadie, omtales ofte som ’desensibilisering’ og menes at være grunden til smertelindringen.
These later-stage effects of capsaicin are frequently referred to as “desensitization” and are thought to underlie the pain relief.
Disse virkninger er hovedsagligt forårsaget af aktivering af nikotin-kolinerge receptorer (nAChR’er).
These effects are caused primarily by activation of nicotinic acetylcholine receptors (nAChRs).
Disse virkninger er ikke relevante i forbindelse med kortvarig administration hos præmature nyfødte børn (se pkt.
These effects are not relevant with regard to short term administration in the preterm infant population (see section 5.3).
Disse virkninger er sjældnere end med oralt kortikosteroid.
These effects are much less likely to occur than with oral corticosteroids.
Disse virkninger forekom ved doser, der ikke gav maternel toksicitet, hvilket tyder på, at dasatinib er selektivt reproduktionstoksisk fra implantering til og med organgenesen er afsluttet.
These effects occurred at doses that did not produce maternal toxicity, indicating that dasatinib is a selective reproductive toxicant from implantation through the completion of organogenesis.
Disse virkninger forekommer at være reversible ved seponering af behandlingen.
These effects appear to be reversible on discontinuing therapy.
Disse virkninger forekommer meget sjældent og er langt mindre tilbøjelige til at forekomme med inhalerede kortikosteroider end med kortikosteroidtabletter.
These effects happen very rarely and are much less likely to happen with inhaled corticosteroids than with corticosteroid tablets.
Disse virkninger forværrer beskadigelsen af makula.
These effects worsen the damage to the macula.
Disse virkninger hævdes at beskytte endotelcellerne.
It is postulated that these actions protect endothelial cells.
Disse virkninger kaldes for interaktioner, og kan i nogle tilfælde medføre alvorlige sygdomstilstande.
These effects are called interactions, and can lead to serious side effects, or prevent proper control of other conditions your child may have.
Disse virkninger recidiverede ikke ved efterfølgende infusioner med en lavere infusionshastighed og indgivelse af lægemidler inden infusion – sædvanligvis lavdosissteroider, antihistaminer og beta-agonister administreret med nebulisator.
These events did not recur with subsequent infusions using a slower infusion rate and administration of pre-infusion medicinal products, usually low-dose steroids, antihistamine, and beta-agonist nebulisation.
Disse virkninger ses kun ved niveauer, der overgik maksimal human eksponering, og det har derfor kun lille betydning i klinikken.
These effects were observed only at exposures considered sufficiently in excess of the maximum human exposure indicating little relevance to clinical use.
Disse virkninger skyldtes hyperprolaktinæmi efter behandling med lurasidon, der påvirker brunst og parringsadfærd samt vedligeholdelse af corpus luteum hos hunrotter, der medfører en reduktion i implantation og antallet af levende fostre.
These effects were due to the hyperprolactinemia following lurasidone treatment, affecting the estrous cycle and copulatory behaviour as well as the maintenance of corpus luteum of the female rats, resulting in a decrease in implantation and the number of live foetuses.
Disse virkninger sås ikke ved doser ≤30 mg/kg.
These effects were not seen at doses ≤30 mg/kg.
Disse virkninger vil blive undersøgt i fremtidige undersøgelser.
These effects will be investigated in further studies.
Disse virkninger vil sandsynligvis ikke observeres ved kliniske forhold..
These effects are unlikely to be observed under clinical conditions.
Disse virus-proteiner er tilberedt af stammen af den influenzavirus, som er i overensstemmelse med Verdenssundhedsorganisationens (WHO) anbefalinger og EU’s bestemmelser vedrørende en officielt erklæret pandemisk situation.
These viral proteins are prepared from the strain of influenza virus that complies with the World Health Organisation recommendations and EU decision in an officially declared Pandemic situation.
Disse virus-proteiner er tilberedt af stammen af den influenzavirus, som er i overensstemmelse med Verdenssundhedsorganisationens (WHO’s) anbefalinger og EU’s bestemmelser vedrørende en officielt erklæret pandemisk situation.
These viral proteins are prepared from the strain of influenza virus that complies with the World Health Organisation recommendations and EU decision in an officially declared Pandemic situation.
Disse viste en tidsmæssig tæt tilknytning og positiv rechallenge og dechallenge, som understøtter en årsagssammenhæng mellem Ganfort / Ganfort i enkeltdosisbeholder og bradykardi.
These showed a close temporal relationship and positive rechallenge and dechallenge which support a causal relationship between Ganfort / Ganfort PF and bradycardia.
Disse viste også, at sevelamercarbonat i både tablet- og pulverform er terapeutisk ækvivalent med sevelamerhydrochlorid.
These also demonstrated that sevelamer carbonate in both tablet and powder formulations are therapeutically equivalent to sevelamer hydrochloride.
Disse værdier forekom som oftest når patienternes initial- og vedligeholdelsesdosis var 150 mg Praluent hver 2. uge uafhængigt af LDL-C-værdi ved baseline eller behandlingsrespons.
These mostly occurred when patients were initiated and maintained on 150 mg Q2W of Praluent regardless of the baseline LDL-C value or the response to treatment.
Disse væv blev fikseret i formalin eller Bouin’s fiksativ.
These tissues were fixed in formalin or Bouin’s fixative.
Disse ændringer anses ikke for at
These changes are not considered
Disse ændringer blev ikke anset for at være klinisk relevante, da den maksimalt tolererede dosis (4-6 mg/m2) af mifamurtid er 2-3 gange højere end den anbefalede dosis (2 mg/m2).
These changes were not considered to be clinically meaningful as the maximum tolerated dose (4-6 mg/m2) of mifamurtide is 2-3 times the recommended dose (2 mg/m2).
Disse ændringer er foreslået på baggrund af PRACs konklusioner efter vurdering af PSUR for zoledronsyre.
These changes are suggested following conclusions by the PRAC upon review of zoledronic acid PSUR.
Disse ændringer er normalt milde og forsvinder efter noget tid.
These changes are usually mild and go away with time.
disse ændringer i
changes in clarithromycin
Disse ændringer inkluderer hævelse, hårdhed, blå mærker, blodansamlinger i huden (hæmatom), udslæt, kløe og ændringer i hudfarven.
These include swelling, a hard lump, bruising, bleeding into your skin (haematoma), rash, itching and changes in the skin colour.
Disse ændringer kan inkludere tab af fedt fra ben, arme og ansigt, øget fedt på maven og omkring indre organer, brystforstørrelse og fedtpukkel i nakken (bøffelnakke).
These may include loss of fat from legs, arms and face, increased fat in the abdomen (belly) and other internal organs, breast enlargement and fatty lumps on the back of the neck (‘buffalo hump’).
Disse ændringer opstår inden for de første måneder af behandlingen, og bliver normalt ikke forværrede, selv om De fortsætter behandlingen.
This change occurs within the first months of treatment and usually doesn’t worsen as you continue treatment.
Disse ændringer var reversible og syntes ikke at have nogen uønskede toksiko- logiske konsekvenser.
These changes were reversible and did not appear to have any adverse toxicological consequences.
Disse ændringer, der også er en klassevirkning for angiotensin- konverterende enzyminhibitorer og andre angiotensin II-receptorantagonister, forekommer ikke at have klinisk signifikans.
These changes, also a class effect of angiotensin converting enzyme inhibitors and other angiotensin II receptor antagonists, do not appear to have clinical significance.
Disse ændringer, som kan være forbundet med anvendelsen af Raptiva, kan normalt kun opdages ved hjælp af blodprøver.
These changes, which may be associated with the use of Raptiva, can usually only be detected with blood tests.
Disse øgninger kan være klinisk relevante ved tilstedeværelse af visse integraseklasseresistenser.
These increases may be clinically relevant in the presence of certain integrase class resistance.
Disseker fibrøst væv væk for at frigøre implantatet, hvis det er nødvendigt.
If necessary, dissect away any fibrous tissue to free the implant.
Dissemineret intravaskulær koagulation, thrombocytose*, hyperviskositetssyndrom, uspecificeret påvirkning af thrombocytfunktionen, thrombocytopenisk purpura, uspecificeret blodsygdom, hæmoragisk diatese, lymfocytinfiltration,
Disseminated intravascular coagulation, Thrombocytosis*, Hyperviscosity syndrome, Platelet disorder NOS, Thrombocytopenic purpura, Blood disorder NOS, Haemorrhagic diathesis, Lymphocytic infiltration
Dissemineret intravaskulær koagulation, trombocytose*, hyperviskositetssyndrom, uspecificeret påvirkning af trombocytfunktionen, trombocytopenisk purpura, uspecificeret blodsygdom, hæmoragisk diatese, lymfocytinfiltration
Disseminated intravascular coagulation, Thrombocytosis*, Hyperviscosity syndrome, Platelet disorder NOS, Thrombocytopenic purpura, Blood disorder NOS, Haemorrhagic diathesis, Lymphocytic infiltration
Dissemineret intravaskulær koagulation, trombocytose*, hyperviskositetssyndrom, uspecificeret påvirkning af trombocytfunktionen, trombocytopenisk purpura, uspecificeret blodsygdom, hæmoragisk diatese, lymfocytinfiltration,
Disseminated intravascular coagulation, Thrombocytosis*, Hyperviscosity syndrome, Platelet disorder NOS, Thrombocytopenic purpura, Blood disorder NOS, Haemorrhagic diathesis, Lymphocytic infiltration
dissemineret sklerose
multiple sclerosis
Dissemineret sklerose (DS) er en kronisk sygdom, der rammer centralnervesystemet (CNS), især funktionen af hjernen og rygmarven.
Mutiple sclerosis (MS) is a long-term condition that affects the central nervous system (CNS), particularly the functioning of the brain and spinal cord.
Dissemineret sklerose er en nervesygdom, der medfører en betændelseslignende tilstand, som ødelægger det beskyttende lag, der omgiver nerverne.
MS is a disease of the nerves, in which inflammation destroys the protective sheath around the nerves.
dissemineret sklerose nerveforstyrrelser (såsom inflammation (betændelse) i synsnerven og Guillain-Barré syndrom, som kan forårsage muskelsvaghed, unormal følesans, prikken i arme og overkrop)
multiple sclerosis nerve disorders (such as eye nerve inflammation and Guillain-Barré syndrome that may cause muscle weakness, abnormal sensations, tingling in the arms and upper body)
Dissemineret sklerose, hævelse af rygmarven (rygmarvsbetændelse)
Multiple sclerosis, swelling of the spinal cord (myelitis)
Dissemineret sklerose, rygmarvsbetændelse
Multiple sclerosis, swelling of the spinal cord (myelitis)
dissemineret sklerose; nerveforstyrrelser (såsom inflammation (betændelse) i synsnerven og Guillain-Barré syndrom, som kan forårsage muskelsvaghed, unormal følesans, prikken i arme og overkrop);
multiple sclerosis; nerve disorders (such as eye nerve inflammation and Guillain-Barré syndrome that may cause muscle weakness, abnormal sensations, tingling in the arms and upper body);
Dista S.A.
Dista S.A..
Distant sygdomsfri overlevelse
Distant disease-free survival
Distant tilbagefald
Distant recurrence
distention, flatulens
flatulence
Distribución
Distribution
Distribuering af produktet
Distribution of the product
Distribuering af præparatet
Distribution of the product
Distribuering og brug af patientbrochurer og behovet for at sikre at patienten har læst og forstået denne
Distribution and use of the patient brochure and the need to ensure that the patient has read and understood the brochure
Distributie
Distribution
Distribution af produktet
Distribution of the product
Distribution:
Distribution
Distribution: Daglige doser på 20 mg giver steady-state-plasmakoncentrationer for memantin på mellem 70 og 150 ng/ml (0,5 - 1 µmol) med store interindividuelle variationer.
Distribution: Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70 to 150 ng/ml (0.5 - 1 μmol) with large inter individual variations.
Distribution: Daglige doser på 20 mg giver steady-state-plasmakoncentrationer for memantin på mellem 70 og 150 ng/ml (0,5 - 1 µmol) med store interindividuelle variationer.
Distribution: Daily doses of 20 mg lead to steady-state plasma concentrations of memantine ranging from 70 to 150 ng/ml (0.5 - 1 μmol) with large interindividual variations.
Distribution: Distributionsvolumenet er 4–8 l/kg.
Distribution: The apparent volume of distribution is 4-8 l/kg.
Distribution: Dyrestudier med somatropin har vist, at væksthormon lokaliseres i organer med høj gennemblødning, især lever og nyrer.
Distribution: Animal studies with somatropin showed that growth hormone localises to highly perfused organs, particularly the liver and kidney.
Distribution: Gennemsnitlig distributionsvolumen efter en enkelt intravenøs dosis rasagilin er 243 l.
Distribution: The mean volume of distribution following a single intravenous dose of rasagiline is 243 l.
Distributionskvoten afhænger af den stedlige topografi og af dyrearternes populationen.
The distribution rate depends on the topography and on the population of the target species.
Distributionskvoten afhænger af den stedlige topografi og af rævepopulationen.
The distribution rate depends on the topography and on the population of the target species.
Distributionsvolumen af frit aflibercept ved steady-state er cirka 8 liter.
The volume of distribution of free aflibercept at steady-state is approximately 8 litres.
Distributionsvolumen er 11 l efter en enkelt intravenøs (i.v.) injektion.
The volume of distribution is 11 l after a single intravenous (IV) administration.
Distributionsvolumen var 60-70 l, hvilket overstiger mængden af den samlede kropsvæske og antyder en moderat vævsdistribution af dabigatran.
The volume of distribution of dabigatran of 60–70 L exceeded the volume of total body water indicating moderate tissue distribution of dabigatran.
Distributionsvolumen ved steady state (dl/kg)
Volume of Distribution at Steady State (dl/kg)
Distributionsvolumenet (Vss) var 4870 l (2640 l/m² for en patient med en median BSA på 1,84 m²) ved steady state.
The volume of distribution (Vss) was 4870 l (2640 l/m² for a patient with a median BSA of 1.84 m²) at steady state.
disulfiram (medicin mod alkoholmisbrug).
disulfiram (used to treat alcohol dependence)
dit aktivitetsniveau i hverdagen er begrænset eller forværres ved behandling.
your level of everyday activities is limited or worsens on treatment.
dit antal af hvide blodlegemer er for lavt.
your number of white blood cells is too low.
Dit barn (i alderen fra 2-6 måneder) skal have tre indsprøjtninger med mindst en måned mellem hver indsprøjtning.
Your child (from 2 months to 6 months of age) will receive three injections with an interval of at least one month between each dose.
Dit barn bør ikke tage Humira sammen med medicin, der indeholder det aktive stof anakinra eller abatacept.
Your child should not take Humira with medicines containing the active substance, anakinra or abatacept.
Dit barn bør indledningsvist have tre injektioner af vaccinen efterfulgt af en fjerde injektion (booster).
Your child should receive an initial course of three injections of the vaccine followed by a fourth injection (booster).
dit barn har blødningstendens eller let får blå mærker dit barn har tendens til krampeanfald i forbindelse med feber, eller hvis der i familien er tilfælde af dette
your child has a bleeding problem or bruises easily your child tends to have fits when they have a fever, or if there is a history of this in the family.
dit barn har haft problemer med nervesystemet inden for 7 dage efter at være blevet vaccineret med vaccine mod kighoste. dit barn har en alvorlig infektion med feber (over 38 C).
your child has had problems of the nervous system within 7 days after previous vaccination with a vaccine against whooping cough. your child has a severe infection with a high temperature (over 38°C).
Dit barn har høj risiko for at få en sygdom forårsaget af den såkaldte respiratoriske syncytialvirus virus (RSV).
Your child is at high risk of getting an illness caused by a virus called respiratory syncytial virus (RSV).
Dit barn kan få synsforstyrrelser og en fornemmelse af at rummet drejer rundt, efter Humira er taget.
Room spinning sensation and vision disturbances may occur after taking Humira.
Dit barn kan have langsommere vækst og udvikling, mens barnet får Pegasys (se punkt 4).
When receiving Pegasys, your child may have slower growth and development (see section 4).
Dit barn må ikke amme, da det nyfødte barn kan blive smittet med hiv- infektionen via mælken.
Your child must not breast-feed the baby because it is possible that the baby can become HIV-infected through the breast milk.